Cargando…
Drug Fever Due to Favipiravir Administration for the Treatment of a COVID-19 Patient
A 55-year-old Japanese man was hospitalized with the novel coronavirus disease 2019 (COVID-19). On the 14th day after the start of favipiravir administration, the patient developed a fever with a temperature of 38.1℃. His pulse rate also became elevated to 128 bpm, so relative bradycardia was not su...
Autores principales: | Tawara, Junsuke, Uehara, Takanori, Sakao, Seiichiro, Igari, Hidetoshi, Taniguchi, Toshibumi, Kasai, Hajime, Takayanagi, Shin, Yahaba, Misuzu, Shimada, Ryo, Ikusaka, Masatomi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079902/ https://www.ncbi.nlm.nih.gov/pubmed/33583886 http://dx.doi.org/10.2169/internalmedicine.5813-20 |
Ejemplares similares
-
Possibility of deterioration of respiratory status when steroids precede antiviral drugs in patients with COVID-19 pneumonia: A retrospective study
por: Shionoya, Yu, et al.
Publicado: (2021) -
COVID-19 infection control education for medical students undergoing clinical clerkship: a mixed-method approach
por: Kasai, Hajime, et al.
Publicado: (2022) -
Clinical Outcomes of Sotrovimab Treatment in 10 High-Risk Patients with Mild COVID-19: A Case Series
por: Takeda, Kenichiro, et al.
Publicado: (2022) -
Tolerability of prone positioning in non‐intubated patients with hypoxaemia due to COVID‐19‐related pneumonia
por: Shikano, Kohei, et al.
Publicado: (2022) -
Accuracy of ChatGPT on Medical Questions in the National Medical Licensing Examination in Japan: Evaluation Study
por: Yanagita, Yasutaka, et al.
Publicado: (2023)